COSCIENS Biopharma Inc T.AEZS

Healthcare Biotechnology

COSCIENS Biopharma Inc., formerly Aeterna Zentaris Inc., is a specialty biopharmaceutical company engaged in the development and commercialization of a diverse portfolio of pharmaceutical and diagnostic products, including those focused on areas of unmet medical need. Its lead product, macimorelin (Macrilen; Ghryvelin), is an oral test indicated for the diagnosis of adult growth hormone deficiency (AGHD). The Company is also engaged in the development of therapeutic assets and proprietary extraction technology, which is applied to the production of active ingredients from renewable plant resources used in cosmeceutical products (i.e., oat beta glucan and avenanthramides, which are found in skincare product brands like Aveeno and Burt’s Bees formulations) and being developed as potential nutraceuticals and/or pharmaceuticals.

TSX:AEZS - Post by User

COSCIENS Biopharma Inc > Long flag

<< Previous

Bullboard Posts

Next >>

Comment by cleareyeon May 19, 2021 9:16am

97 Views

Post# 33228890

RE:RE:Long flag

Bobinpinelarew07,

Good point about the gap.

Gaps are tricky and sometimes they're not as clean as others. For example, the downdraft on March 5th with a low of 0.99 was below the price on January 28th, but not below the high price of .91 on February 1st, nor below the close of .89 on Feb.1.

So, we wait for confirmation. And we wait to see if there is a false confirmation or if we wish to make it personal, a head-fake.

It's May and most trends are down.

Is it an exceptional year? Not for my portfolio. I have often realized that if I had sold everything on March 15th I would be much farther ahead in mid-May. Forget "sell in May and go away";that's what everyone else does!

So, we wait. Maybe we hold a core position. Maybe not.

As you can see, I am really uncertain in mid-May. LOL

cleareye.

<< Previous

Bullboard Posts

Next >>

How to navigate the ups and downs of investing in AI